The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > News > Physiogenex to present at the Keystone Obesity and Adipose Tissue Biology in Banff, Alberta, Canada

News detail

Return to all news & events

02/06/2019 Physiogenex to present at the Keystone Obesity and Adipose Tissue Biology in Banff, Alberta, Canada

Physiogenex will present at the Keystone Symposia Obesity and Adipose Tissue Biology, on February 11, 2019 during the Poster Session 1 (19:30 – 22:00).

Poster (#1021):  Green coffee better improves body weight loss and metabolic disorders than green tea in diet-induced obese mice”.

Dr. François Briand, Director of Research and Business Development will be happy to discuss with you about your preclinical obesity project, explore it and share with you his expertise. Please contact us to set-up an appointment.

About us

Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.

We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.